Conjugated Estrogens for the Management of Bleeding Associated with Renal Failure
- 18 September 1986
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 315 (12) , 731-735
- https://doi.org/10.1056/nejm198609183151204
Abstract
Bleeding is a major complication of uremia. Both cryoprecipitate and desmopressin effectively shorten the prolonged bleeding time and favorably influence clinical bleeding, but the former carries the risk of transmitting blood-borne infectious diseases, and both cryoprecipitate and desmopressin have a short duration of action. Preliminary evidence has suggested that estrogens may be useful, and we therefore performed a randomized, double-blind, crossover trial comparing the effect of conjugated estrogens with that of placebo on hemorrhagic tendencies and the bleeding time in six patients with uremia who were on maintenance hemodialysis.This publication has 25 references indexed in Scilit:
- REDUCED RESPONSE OF URAEMIC BLEEDING TIME TO REPEATED DOSES OF DESMOPRESSINThe Lancet, 1985
- TREATMENT OF URAEMIC BLEEDING WITH CONJUGATED OESTROGENThe Lancet, 1984
- Intranasal Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaAmerican Journal of Nephrology, 1984
- Reduced Platelet Thromboxane Formation in Uremia. EVIDENCE FOR A FUNCTIONAL CYCLOOXYGENASE DEFECTJournal of Clinical Investigation, 1983
- Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaNew England Journal of Medicine, 1983
- Effect of 1-Deamino-8-D-Arginine Vasopressin on the Prolonged Bleeding Time in Chronic Renal FailureNephron, 1982
- Impaired Platelet Thromboxane Production in Renal FailureNephron, 1981
- Treatment of the Bleeding Tendency in Uremia with CryoprecipitateNew England Journal of Medicine, 1980
- Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendotheliumNature, 1979
- PROSTACYCLIN-LIKE ACTIVITY AND BLEEDING IN RENAL FAILUREThe Lancet, 1977